Events
Pharmaceutical Leader to Call for Common European Standards on Cannabis Medicines
A pharmaceutical executive leading work on international cannabis standards will speak at medical cannabis conferences in Frankfurt and London this autumn.
Ana Serrato, Head of Drug Development at Avextra and chair of the European Medicinal Cannabis Association, will speak at both Cannabis Health Symposiums in Frankfurt and London about efforts to create common standards for cannabis-based medicines across Europe.
She also chairs an international standards group focused on the quality, safety and use of cannabis-based medicines. The group sits within ASTM International’s cannabis committee and is known as the Human Health Subcommittee, D37.11.
Ahead of the November events, Serrato said: “Trusted cannabinoid-based care will not come from national regulation alone – it requires one shared standard, built for the full journey from product to patient.”
At the Frankfurt symposium on 4 November, Serrato will take part in a panel examining whether Europe needs a common pharmaceutical quality framework for medical cannabis.
At the London symposium on 26 November, she will discuss how greater harmonisation could give manufacturers “one consistent technical reference”, healthcare professionals “reliable evidence to guide prescribing”, patients “assurance of quality and safety” and regulators “a harmonised benchmark”.
Secure your place
The Cannabis Health Symposium Frankfurt takes place on 4 November, followed by the London symposium on 26 November.
Both events will bring together healthcare professionals, researchers, patient advocates and industry figures to discuss the latest developments in medical cannabis research, prescribing, regulation and patient care.
Secure your place at the Cannabis Health Symposium Frankfurt or London here
Get the weekly briefing
A round-up of the latest science, regulation and developments across the UK and Europe — in your inbox every week.